Mrs. Vivian Celeste Crites, LCISW,LMFT,LCDC,SAP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4004 Rhymer Highway, Suite 2-5 Doctor's Park Ii, St. Thomas, VI 00802 Phone: 340-777-9363 Fax: 340-775-3983 |
Ms. Bonita Marie Roy, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9149 Estate Thomas, Paragon Medical Bldg Suite 209a, St. Thomas, VI 00802 Phone: 340-774-2228 Fax: 340-714-8159 |
Dr. Barbara Mactavious Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: Barbel Plaza South, The Ross Building, First Floor, St. Thomas, VI 00802 Phone: 340-774-7700 Fax: 340-774-4701 |
News Archive
Powerful new technologies that zoom in on the connections between human genes and diseases have illuminated the landscape of cancer, singling out changes in tumor DNA that drive the development of certain types of malignancies such as melanoma or ovarian cancer.
Recent research found that microneedle vaccine patches are more effective at delivering protection against influenza virus in mice than subcutaneous or intramuscular inoculation. A new, detailed analysis of the early immune responses by the Emory and Georgia Tech research team helps explain why the skin is such fertile ground for vaccination with these tiny, virtually painless microneedles.
In a study available on the medRxiv* the preprint server, researchers from Spain showed that testosterone trajectories are very accurate individual predictors of survival in male patients with COVID-19. To better understand the relationship between testosterone levels and disease severity, they studied a group of male and female COVID-19 patients assessing their serum and blood biomarkers in association with outcome of disease.
Scientists at the Schepens Eye Research Institute, an affiliate of Harvard Medical School, have identified a key mechanism for successfully transplanting tissue into the adult central nervous system.
Controlling HIV/AIDS in India is an "immense" challenge for the country's National AIDS Control Organization - which is preparing to launch on April 1 the third phase of its National AIDS Control Program, a new five-year, $2.6 billion program that aims to reduce the number of new HIV cases and improve access to treatment in the country - NEJM national correspondent Robert Steinbrook writes in a perspective piece.
› Verified 2 days ago